Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Shares Up Despite 58-Percent Plunge in Q3 Revenue

This article has been updated to include share price.

NEW YORK, Nov. 4 (GenomeWeb News) - Shares in Large Scale Biology were up 3.16 percent at $.98 despite a 58-percent plunge in third-quarter revenue.

 

LSB, owner of Predictive Diagnostics, today said that third-quarter revenue fell to $500,000 from $1.2 million one year ago. The Vacaville, Calif.-based company did not break out figures for its wholly owned biomarker-company subsidiary.

 

LSB attributed the severe decline to the loss of $800,000 in revenues generated during the third quarter of 2003 by its Germantown, Md.-based contract proteomics business, which it closed last November (see ProteoMonitor, GenomeWeb News' sister publication).

The company spent $2.3 million on R&D in the period, down slightly from $2.7 million year over year.

Consequently, net losses for the third quarter narrowed to $4.2 million, or $.13 per share, from $4.3 million, or $.17 per share, in 2003.

 

The results do not include one full quarter of activity related to Predictive Diagnostics' agreement with PerkinElmer, which the companies announced in late September. Under the agreement, PerkinElmer will offer the Predictive Diagnostics' Biomarker Amplification Filter technology to complement its own prOTOF 2000 MALDI O-TOF mass spectrometer.

LSB ended the quarter with $3.9 million in cash and marketable securities.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.